Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC-CTL Cells and Decitabine in Malignant Tumors
NCT04672473Phase 2Unknown
- Sponsor
- Shenzhen University General Hospital
- Start
- Oct 2020
- Primary completion
- Jul 2023
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of tumor polypeptide pool induced DC-CTL cells in cancer, sponsored by Shenzhen University General Hospital. Status: unknown.
02
Drugs
tumor polypeptide pool induced DC-CTL cells
03
Conditions
cancer
Beyond the preview
Go deeper on NCT04672473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04672473.